Download PDFPDF

796 Pegylated liposomal doxorubicin chemotherapy, Flt3 ligand, and CD40 agonist triplet combination improves tumor control in breast cancers
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address